CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- 4 Open-market buy Director bought 1,358,448 shares at $1.04 ($1,415,095)
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Unregistered share sale
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 10-K Report Annual Report
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 4 Returned to the company Chief Executive Officer returned 10,261 shares (to the company)
- 4 Returned to the company Chief Medical Officer returned 2,975 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 1,150 shares (to the company)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Returned to the company Chief Financial Officer returned 258 shares (to the company)
- 8-K Event Delisting notice
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Returned to the company Chief Operating Officer returned 1,130 shares (to the company)
- 4 Open-market buy Director bought 300,000 shares at an average $0.17 ($50,000)
- 4 Grant or award Director acquired 80,000 shares (grant or award)
Page 9 of 28 · 549 filings